ÂÜÀòÂÒÂ×

Christine Redmond is an experienced leader in clinical operations and program management, currently serving as the Head of Clinical Operations and Program Management at Ratio Therapeutics since March 2024. Prior to this role, Christine held significant positions at the Bill & Melinda Gates Medical Research Institute as Portfolio Leader for Tuberculosis, Malaria, and Shigella, and at ARC Clinical Solutions as Principal Owner, where consulting services were provided to biotech and pharma companies. Christine's tenure at Biogen as Senior Director included leadership of multiple sclerosis and immunology programs. Additional roles include senior director positions at Synta Pharmaceuticals, Lantheus Medical Imaging, Molecular Insight Pharmaceuticals, Dyax Corporation, and Acorda Therapeutics. Christine holds a Bachelor of Arts in Biology from Wheaton College Massachusetts and a Master of Public Health in Epidemiology from the University of Massachusetts Amherst.